Companies are using an electron-beam 3-D printing process to manufacture medical implants.
Two SLAC physicists with decades of particle accelerator experience helped a Silicon Valley company design and build X-ray devices that scan cargo containers for nuclear materials and other hazards. A version of this screening system is now in commercial use, and on May 16, the company received national recognition for its successful development from the federal Small Business Administration.
Last year's Nobel Prize in Chemistry – shared by Stanford School of Medicine Professor Brian Kobilka and Robert Lefkowitz of Duke University – recognized groundbreaking research in G protein-coupled receptors (GPCRs). GPCRs are embedded in cell membranes. They interact with signaling molecules outside of cells and trigger responses within cells.
Understanding why proteins interact with certain specific molecules and not with the myriad others in their environment is a major goal of molecular biology. Now, in a series of recent papers, researchers describe how they designed proteins from scratch to have a high affinity and high specificity for targets on flu viruses, and then validated the two best designs using X-ray diffraction data collected at the Stanford Synchrotron Radiation Lightsource (SSRL).